We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
-1.24%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
–
AUM
$3.24B
AUM Growth
+$189M
Cap. Flow
+$267M
Cap. Flow %
8.23%
Top 10 Hldgs %
14.64%
Holding
4,718
New
239
Increased
1,450
Reduced
1,097
Closed
452

Top Buys

Rank Stock Value
1
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$25M
2
AAPL icon
Apple
AAPL
+$19.9M
3
VUG icon
Vanguard Growth ETF
VUG
+$17.5M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$15.4M
5
VGT icon
Vanguard Information Technology ETF
VGT
+$14.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$32.1M
2
GJUL icon
FT Vest US Equity Moderate Buffer ETF July
GJUL
+$11.3M
3
FNOV icon
FT Vest US Equity Buffer ETF November
FNOV
+$10.8M
4
DJAN icon
FT Vest US Equity Deep Buffer ETF January
DJAN
+$10.2M
5
UCON icon
First Trust Smith Unconstrained Bond ETF
UCON
+$9.45M

Sector Composition

Rank Sector Weight
1 Technology 10.65%
2 Financials 4.62%
3 Healthcare 3.7%
4 Consumer Discretionary 3.47%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKLA
4276
DELISTED
Nikola Corporation Common Stock
NKLA
$4 ﹤0.01%
36
-7
-16% -$6
BTMD icon
4277
Biote Corp
BTMD
$68.5M
$3 ﹤0.01%
1
– –
BZUN
4278
Baozun
BZUN
$167M
$3 ﹤0.01%
1
– –
CDXS icon
4279
Codexis
CDXS
$136M
$3 ﹤0.01%
1
– –
FDMT icon
4280
4D Molecular Therapeutics
FDMT
$513M
– –
0
– –
NMRA icon
4281
Neumora Therapeutics
NMRA
$309M
– –
0
– –
RFEM icon
4282
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$76.8M
– –
0
– –
TALK icon
4283
Talkspace
TALK
$874M
– –
0
– –
UAVS icon
4284
AgEagle Aerial Systems
UAVS
$40.6M
$3 ﹤0.01%
2
-383
-99% -$762
VGAS icon
4285
Verde Clean Fuels
VGAS
$25.1M
$3 ﹤0.01%
1
– –
OVID icon
4286
Ovid Therapeutics
OVID
$427M
$2 ﹤0.01%
8
– –
PSTX
4287
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
0
– –
AKYA
4288
DELISTED
Akoya BioSciences
AKYA
$1 ﹤0.01%
1
– –
HOWL icon
4289
Werewolf Therapeutics
HOWL
$21.7M
$1 ﹤0.01%
1
– –
INZY
4290
DELISTED
Inozyme Pharma
INZY
$1 ﹤0.01%
1
– –
LCTX icon
4291
Lineage Cell Therapeutics
LCTX
$262M
$1 ﹤0.01%
3
– –
MGNX icon
4292
MacroGenics
MGNX
$242M
– –
0
– –
PMCB icon
4293
PharmaCyte Biotech
PMCB
$6.33M
$1 ﹤0.01%
+1
New +$2
XXII
4294
22nd Century Group
XXII
$1.35M
– –
0
– –
ACCO icon
4295
Acco Brands
ACCO
$399M
– –
-4
Closed -$21
ACMR icon
4296
ACM Research
ACMR
$5.08B
– –
-21
Closed -$468
ADAP
4297
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-3,023
Closed -$1.63K
ADUS icon
4298
Addus HomeCare
ADUS
$2.22B
– –
-1
Closed -$125
AEMD icon
4299
Aethlon Medical
AEMD
$1.45M
– –
-136
Closed -$9.38K
AEYE icon
4300
AudioEye
AEYE
$76.6M
– –
-7
Closed -$106
170 171
172
173 174

Similar funds

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return

IFP Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, IFP Advisors held 4,718 positions worth $3.24B, up 6.2% from $3.05B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

IFP Advisors deployed $267M of net new capital in Q1 2025, opening 239 new positions and adding to 1,450 existing holdings. Its largest new stake was MRP SynthEquity ETF: 119,146 shares worth $2.92M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $32.1M trimmed.

  • IFP Advisors's largest Q1 2025 buy was MRP SynthEquity ETF: 119,146 shares worth $2.92M.
  • IFP Advisors added most to First Trust Enhanced Short Maturity ETF in Q1 2025, an estimated $25M increase.
  • IFP Advisors's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $32.1M.
  • IFP Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q1 2025, selling an estimated $6.2M.
  • IFP Advisors's ten largest holdings make up 15% of its $3.24B portfolio in Q1 2025.
  • IFP Advisors opened 239 new positions and closed 452 in Q1 2025.
  • IFP Advisors's portfolio value rose 6.2% quarter-over-quarter to $3.24B.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.